Brief: Vect-Horus Enters Into Collaboration And License Agreement With Ono Pharmaceutical Co Ltd
March 26 (Reuters) - Ono Pharmaceutical Co Ltd 4528.T :
* VECT-HORUS ENTERS INTO COLLABORATION AND LICENSE AGREEMENT
WITH
ONO PHARMACEUTICAL CO., LTD.
* VECT-HORUS S.A.S. - VECT-HORUS WILL RECEIVE RESEARCH FEES,
SUCCESS-BASED MILESTONES ON RESEARCH AND DEVELOPMENT PROGRESS
* VECT-HORUS S.A.S. - VECT-HORUS WILL RECEIVE ROYALTIES ON
SALES
OF PRODUCTS.
* VECT-HORUS - ONO TO HAVE WORLDWIDE RIGHTS TO DEVELOP AND
COMMERCIALIZE ANY PHARMACEUTICAL PRODUCTS ARISING OUT OF DRUG
DISCOVERY COLLABORATION
Source text for Eikon: ID:nBwbmnXc7a
Further company coverage: 4528.T
(Reuters.Briefs@thomsonreuters.com)
Recent news on ONO PHARMACEUTICAL
See all newsBrief: Biohaven Enters Strategic Licensing Agreement With Ono Pharma
Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean
Bristol Myers sues Amgen over proposed Opdivo biosimilar (updated)
Bristol Myers sues Amgen over proposed Opdivo biosimilar
Brief: UK's MHRA Says Vimseltinib Approved For Use In Adults To Treat Tenosynovial Giant Cell Tumours